Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Orchid Chemicals & Pharmaceuticals Ltd Announces Extension Of Financial Year For 2012-2013 Up To 18 Months


Wednesday, 26 Jun 2013 03:56am EDT 

Orchid Chemicals & Pharmaceuticals Ltd announced that the Board of Directors of the Company through circular resolution passed on June 24, 2013 have approved the extension of financial year 2012-2013 of the Company by a further period of 3 (three) months i.e. upto September 30, 2013. 

Company Quote

75.35
-0.1 -0.13%
5:34am EDT